Source study found
Story checked
Finding the cells that put our brain to sleep - Ars Technica (opens in a new tab)
arstechnica.com · 2026-09-18
Short answer
Mostly not supportedMostly not supported.
The claims we could check match the study, but some claims were not covered by the evidence reviewed.
- 1 supported
- 5 not covered
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Finding the cells that put our brain to sleep - Ars Technica
arstechnica.com · 2026-09-18
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Mostly not supported
The one claim we could check holds up. One of six claims matches the study. This overall rating is based only on the claims we could check. Five claims the study doesn't address.
- 1 supported
- 5 not covered
The source study
Neocortical long-range inhibition promotes cortical synchrony and sleep
Evidence layer
Claim by claim
Each claim gets a verdict. Expand it to see the evidence directly below.
Reading mode
Scan verdicts. Open evidence only when needed.
Browse by verdict
6 claims in this storyShowing all 6 claimsChoose a verdict to focus the list.
Claim 1 of 6Not coveredThe cells, called Sst-Chodl neurons, make up about one percent of the cortex’s inhibitory neurons, and switching them on in a mouse puts the animal to sleep.View evidenceHide evidence
As statedaround 1% of inhibitory neurons
Why this verdict
The activation portion is supported at abstract depth: selective activation of Sst–Chodl cells is reported to be sufficient to induce sleep in mice. However, the stated prevalence of about 1% of cortical inhibitory neurons is not present in the abstract-level profile, which only describes the cells as sparse or extremely sparse, so the full claim cannot be verified at this depth.
Study evidence
Sst–Chodl neocortical inhibitory neurons are selectively active during low‑arousal/sleep states and are mostly silent during high‑arousal/wake periods in mice.
“Here we show in mice that cells co-expressing somatostatin (Sst) and chondrolectin (Chodl) ... are selectively active during low-arousal states and mostly silent during periods of high arousal.”
Study evidence
Selective activation of Sst–Chodl neurons is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep in mice.
“Selective activation of Sst-Chodl cells is sufficient to promote the multi-region cortical synchronization that is characteristic of low-arousal states and to induce sleep.”
Claim 2 of 6Not coveredIn the experiment, 95 of 111 imaged Sst-Chodl cells were active during slow-wave sleep and quiet wakefulness and were silent during running and REM sleep.View evidenceHide evidence
As stated95 out of 111 cells
Why this verdict
The abstract-level profile supports the general state-dependence claim that Sst–Chodl cells are active in low-arousal/sleep states and mostly silent during high arousal. It does not provide the specific count of 95/111 cells, the imaging modality, or the detailed state breakdown involving quiet wakefulness, running, slow-wave sleep, and REM sleep.
Study evidence
Sst–Chodl neocortical inhibitory neurons are selectively active during low‑arousal/sleep states and are mostly silent during high‑arousal/wake periods in mice.
“Here we show in mice that cells co-expressing somatostatin (Sst) and chondrolectin (Chodl) ... are selectively active during low-arousal states and mostly silent during periods of high arousal.”
Claim 3 of 6Not coveredOptogenetic stimulation of Sst-Chodl cells in the visual cortex increased delta power, tightened spike timing, and made DOWN states more frequent and longer.View evidenceHide evidence
Why this verdict
The profile supports a general causal claim that selective activation promotes multi-region cortical synchronization characteristic of low-arousal states. But the abstract-level evidence does not specify optogenetic stimulation, visual cortex, delta power, spike timing, or DOWN-state frequency and duration, so these detailed physiological endpoints are not verifiable here.
Study evidence
Selective activation of Sst–Chodl neurons is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep in mice.
“Selective activation of Sst-Chodl cells is sufficient to promote the multi-region cortical synchronization that is characteristic of low-arousal states and to induce sleep.”
Claim 4 of 6Not coveredActivating the cells across the cortex of freely moving mice increased slow-wave and REM sleep, reduced sleep latency, and made the animals go into their nests during the day.View evidenceHide evidence
Why this verdict
The abstract-level profile supports the core causal claim that selective activation can induce sleep in mice. It does not verify the more specific claims that activation across cortex in freely moving mice increased slow-wave and REM sleep, reduced sleep latency, or caused daytime nest entry.
Study evidence
Selective activation of Sst–Chodl neurons is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep in mice.
“Selective activation of Sst-Chodl cells is sufficient to promote the multi-region cortical synchronization that is characteristic of low-arousal states and to induce sleep.”
Claim 5 of 6Not coveredThe researchers say the cells may act as sensors of sleep pressure, but the article notes they do not yet know what activates them.View evidenceHide evidence
Why this verdict
The profile supports that Sst–Chodl activity tracks arousal state, which is related to the idea that the cells may monitor sleep-related state. However, the specific speculation that they may act as sensors of sleep pressure, and the caveat that researchers do not know what activates them, are not present in the abstract-level profile.
Study evidence
Sst–Chodl neocortical inhibitory neurons are selectively active during low‑arousal/sleep states and are mostly silent during high‑arousal/wake periods in mice.
“Here we show in mice that cells co-expressing somatostatin (Sst) and chondrolectin (Chodl) ... are selectively active during low-arousal states and mostly silent during periods of high arousal.”
Claim 6 of 6SupportedA recent Nature study reported a population of cortical cells that challenges the assumption that sleep is controlled only by subcortical regions.View evidenceHide evidence
Why this verdict
The abstract-level profile supports the broad point that a genetically distinct neocortical inhibitory neuron population tracks arousal state and that selective activation can induce sleep, which reasonably challenges a view that sleep control is exclusively subcortical. The profile does not independently document the prior assumption, but the story’s hedged framing is consistent with the paper’s cortical sleep-regulation claim.
Study evidence
Sst–Chodl neocortical inhibitory neurons are selectively active during low‑arousal/sleep states and are mostly silent during high‑arousal/wake periods in mice.
“Here we show in mice that cells co-expressing somatostatin (Sst) and chondrolectin (Chodl) ... are selectively active during low-arousal states and mostly silent during periods of high arousal.”
Study evidence
Selective activation of Sst–Chodl neurons is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep in mice.
“Selective activation of Sst-Chodl cells is sufficient to promote the multi-region cortical synchronization that is characteristic of low-arousal states and to induce sleep.”
Context layer
What the story left out
Important study details the story did not include.
The paper reports that Sst–Chodl neurons have long-range axons targeting multiple neocortical regions simultaneously, providing a possible substrate for widespread inhibitory influence across cortex.
The story summary and claims emphasize sleep induction and cortical coordination, but the supplied presentation does not clearly report the anatomical long-range axon/multi-region projection finding as a distinct paper result.
From anatomical/circuit mapping (cell-type-specific labeling and axonal projection mapping)
3 things the story did carry across
- The paper identifies Sst–Chodl cells as a sparse, genetically distinct neocortical inhibitory neuron class whose activity tracks behavioral/arousal state, with activity in low-arousal/sleep states and relative silence during high arousal.
- The paper’s central causal claim is that selective activation of Sst–Chodl cells is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep in mice.
- The evidence is from mice; applicability beyond the mouse model, including to humans, is not established in the abstract-level profile.
Study layer
Study at a glance
Scan the study first. Expand only the parts you want to inspect.
Pieces of work
3
Evidence read
study summary
Lead result
in vivo animal
1Lead resultin vivo animalTest causality: selective activation of Sst–Chodl neurons promotes multi-region cortical synchrony characteristic of low-arousal states and is sufficient to induce sleep.Cell-type-specific activation (causal intervention)ExpandCollapse
In plain English
In mice, selective activation of a sparse, genetically defined class of neocortical GABAergic neurons co-expressing Sst and Chodl is reported to be sufficient to (1) promote multi-region low-frequency cortical synchrony characteristic of low-arousal states and (2) induce sleep. The claim is presented as a causal intervention showing that long-range Sst–Chodl inhibitory neurons can actively drive coordinated cortical dynamics and sleep behavior.
Key findings
- Selective activation of Sst–Chodl neurons is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep in mice.
“Selective activation of Sst-Chodl cells is sufficient to promote the multi-region cortical synchronization that is characteristic of low-arousal states and to induce sleep.”
What this piece can’t prove
- The abstract states a sufficiency claim but does not provide effect magnitude, reproducibility metrics, or potential off-target/ancillary effects of the activation method.
1 further detail could not be confirmed from the summary.
2in vivo animalIdentify a genetically distinct neocortical inhibitory neuron class (Sst–Chodl) whose activity tracks behavioural/arousal state (active in low-arousal/sleep, silent in high-arousal).in vivo mouse state recordingExpandCollapse
In plain English
In mice, the paper identifies a sparse, genetically distinct class of neocortical GABAergic inhibitory neurons that co‑express somatostatin (Sst) and chondrolectin (Chodl) and reports that these Sst–Chodl cells are selectively active during low‑arousal states including sleep and are mostly silent during periods of high arousal/wake, based on in vivo cell‑type‑targeted recordings combined with behavioural/arousal state scoring.
Key findings
- Sst–Chodl neocortical inhibitory neurons are selectively active during low‑arousal/sleep states and are mostly silent during high‑arousal/wake periods in mice.
“Here we show in mice that cells co-expressing somatostatin (Sst) and chondrolectin (Chodl) ... are selectively active during low-arousal states and mostly silent during periods of high arousal.”
What this piece can’t prove
- Abstract‑level report lacks methodological detail needed to evaluate measurement approach (recording modality, numbers of cells/animals, selection criteria, and statistical analysis).
1 further detail could not be confirmed from the summary.
3in vivo animalDemonstrate that Sst–Chodl neurons have long-range axons that provide widespread, multi-region inhibitory influence across neocortex (anatomical/circuit mapping of long-range inhibition).anatomical/circuit mapping (cell-type-specific labeling and axonal projection mapping)ExpandCollapse
In plain English
The paper reports that a sparse, genetically distinct class of neocortical GABAergic neurons co-expressing somatostatin (Sst) and chondrolectin (Chodl) possess long-range axons that target multiple neocortical regions simultaneously, providing a basis for widespread, multi-region inhibitory influence across the neocortex.
Key findings
- Sst–Chodl inhibitory neurons, though extremely sparse, have long-range axons that target multiple neocortical regions simultaneously and are reported to exert widespread influence across the neocortex.
“In contrast to most neocortical inhibitory neurons, Sst–Chodl cells, despite being extremely sparse, exert widespread influence across the neocortex, through long-range axons that target multiple regions simultaneously.”
What this piece can’t prove
- Specific target regions within neocortex and the extent/strength of projections are not listed.
2 further details could not be confirmed from the summary.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Neocortical long-range inhibition promotes cortical synchrony and sleep
Nature · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Europe PMC, Crossref · 15 candidate papers
Neocortical long-range inhibition promotes cortical synchrony and sleep
Nature · 2026 · PubMed, Europe PMC, Crossref
Review for "GABA A receptor β 1 ‐subunit knock‐out mice show increased delta power in NREM sleep and decreased theta power in REM sleep"
2020 · Crossref
Dysfunction of cortical GABAergic projection neurons as a major hallmark in a model of neuropsychiatric syndrome.
Neuron · 2025 · PubMed
Review for "GABA A receptor β 1 ‐subunit knock‐out mice show increased delta power in NREM sleep and decreased theta power in REM sleep"
2021 · Crossref
Decoding Brain Development and Function Through GABAergic Inhibitory Neurons.
2026 · Europe PMC
Neocortical long-range inhibition promotes cortical synchrony and sleep.
bioRxiv : the Preprint Server for Biology · 2024 · PubMed, Europe PMC
And 9 more candidates considered.